UK markets open in 7 hours 39 minutes

Oxford BioMedica plc (OXB.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,634.00+156.00 (+10.55%)
At close: 4:35PM BST
Currency in GBp

Valuation measures

Market cap (intra-day) 51.35B
Enterprise value 31.18B
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)15.40
Price/book (mrq)1,192.70
Enterprise value/revenue 313.49
Enterprise value/EBITDA 7329.22

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 375.74%
S&P500 52-week change 334.52%
52-week high 31,668.00
52-week low 3774.33
50-day moving average 31,434.44
200-day moving average 31,215.89

Share statistics

Avg vol (3-month) 3133.48k
Avg vol (10-day) 3368.03k
Shares outstanding 582.66M
Implied shares outstanding 6N/A
Float 60.67M
% held by insiders 16.79%
% held by institutions 171.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)31 Dec 2020


Profit margin -7.12%
Operating margin (ttm)-5.54%

Management effectiveness

Return on assets (ttm)-1.98%
Return on equity (ttm)-6.63%

Income statement

Revenue (ttm)87.73M
Revenue per share (ttm)1.10
Quarterly revenue growth (yoy)68.20%
Gross profit (ttm)46.07M
Net income avi to common (ttm)-6.25M
Diluted EPS (ttm)-7.80
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)46.98M
Total cash per share (mrq)0.57
Total debt (mrq)13.85M
Total debt/equity (mrq)12.28
Current ratio (mrq)2.06
Book value per share (mrq)1.37

Cash flow statement

Operating cash flow (ttm)3.12M
Levered free cash flow (ttm)-6.82M